Editing Polyneuropathy (section)

==Treatment==
[[File:Methylprednisolone.png|thumb|Methylprednisolone]]
In the treatment of polyneuropathies one must ascertain and manage the cause, among management activities are: weight decrease, use of a walking aid, and [[occupational therapist]] assistance. Additionally, BP control in those with diabetes is helpful, while intravenous [[immunoglobulin]] is used for multifocal motor neuropathy.<ref name=pat/>

According to Lopate, et al., [[methylprednisolone]] is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin). The authors also indicate that [[prednisone]] has greater adverse effects in such treatment, as opposed to intermittent (high-doses) of the aforementioned medication.<ref name=pat/><ref>{{cite journal|last1=Lopate|first1=Glenn|last2=Pestronk|first2=Alan|last3=Al-Lozi|first3=Muhammad|title=Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone|journal=Archives of Neurology|date=1 February 2005|volume=62|issue=2|pages=249–54|doi=10.1001/archneur.62.2.249|issn=0003-9942|pmid=15710853|doi-access=free}}</ref>

According to Wu, et al., in [[critical illness polyneuropathy]] supportive and preventive therapy are important for the affected individual, as well as, avoiding (or limiting) [[corticosteroids]].<ref>{{cite journal|last1=Zhou|first1=Chunkui|last2=Wu|first2=Limin|last3=Ni|first3=Fengming|last4=Ji|first4=Wei|last5=Wu|first5=Jiang|last6=Zhang|first6=Hongliang|title=Critical illness polyneuropathy and myopathy: a systematic review|journal=Neural Regeneration Research|date=1 January 2014|volume=9|issue=1|pages=101–110|doi=10.4103/1673-5374.125337|pmc=4146320|issn=1673-5374|pmid=25206749 |doi-access=free }}</ref>